FindTrial
Sign In

Research on mechanisms of acquired maternal antibodies against respiratory syncytial virus infection in infants

Research on mechanisms of acquired maternal antibodies against respiratory syncytial virus infection in infants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018718
Enrollment
Unknown
Registered
2018-10-05
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory syncytial virus infection in infants

Interventions

Case series:no

Sponsors

Children's hospital of chongqing medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The pregnant women which will give birth between 2018.11-2019.01 and their babies.

Exclusion criteria

Exclusion criteria: Women with pregnancy-induced hypertension syndromes, gestational diabetes mellitus,immunodeficeny diseases and babies with congenital heart diseases, nervous system diseases, hematological system diseases and immunodeficiency diseases.

Design outcomes

Primary

MeasureTime frame
The antibody titers;The antibody efficacy levels;wheeze;—

Countries

China

Contacts

Public ContactDaiyin Tian

Children's Hospital of Chongqing Medical University

t_dy@163.com+86 13883048530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026